Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- 9Th Biennial Aaos/Ases Shoulder & Elbow: Current Techniques and Controversies
- 9Th Immunology of Diabetes Society Research Symposium
- 9Th International Myotonic Dystrophy Consortium Conference
- 9th International Workshop on Autoantibodies and Autoimmunity
- A 10 Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate The
- A 12 Month Dose Level Blinded Study Investigating the Safetyand Efficacy of Cvt 301 (Levodopa Inhalation Powder)
- A 12 Month Double-Blind, Randomized Multicenter, Active Controlled, Parallel Group Study Comparing the Efficacy and ....
- A 12 Month Randomized Rater and Dose Blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25Mg ....
- A 12 Month, Multi-Center, Randomized, Open-Label Non- Inferiority Study Comparing the Safety and Efficacy . . .
- A 12 Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of Gabitril Treatment (Up to 16mg Per
- A 12 Week Multi-Ctr Dbl-Bld Rndmzd Plcb-Cntrl Dose Response Stdy of the Anti-Viral Effct of Oral Ut-231b in Non-Cicchoti
- A 12 Week Randomized, Open-Labeled, 3-Arm,Parallel Group Multicenter,Phase IIIb Study Comparing the Efficancy......
- A 12 Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter, Fixed Dose-Response Study To
- A 12 Week, Open-Label, Safety Trial of Pregabalin in Patients with Fibromyalgia
- A 12 Week, Prospective, Open-Label, Multicenter, Cohort Study to Assess Hiv-Patient Quality of Life and Tolerability....
- A 12-Month Follow-Up Study to the Act34-Cmi Study (Baxter Trac-R 34976 Study)
- A 12-Month Follow-Up Study to the Act34-Cmi Study (Baxter Trac-R 34976 Study)
- A 12-Month Opn-Lbl Flexible-Dosage Stdy to Eval the Safety of Gabitril at Dosages Up to 16mg/Day in Adults W/Chronic
- A 12-Week Dbl Blind Placebo Controlled Randomized Parallel Group Multicenter Fixed Dose Study to Evaluate the Efficacy
- A 13-Week Training of One 2010 Cocoa Borlaug Fellow From Nigeria Moses Ogunlade
- A 14 Week Placebo-Controlled Dose-Response Efficacy and Safetystudy of Ns 2330 in Early Parkinsons Disease Patients...
- A 16- Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy of Quinapril in Patients with Coronary Artery Disease, Silent Ischemia, and Effort-Induced Angina
- A 2-Part, Randomized, D-Blind/Sponsored Unblinded, Single- Dose Study of the Safety & Tolerability of 150 Mg Moa-728...
- A 21St Century Approach to Electronic Device Reliability
- A 24 Week International Multi-Center Randomized Parallel- Group Double-blind Trial to Evaluate Metformin.....
- A 24 Week Randomised, Double Blind, Multi Centre Placebo Controlled Study to Evaluate the Efficacy, Safety and ........
- A 24 Week Randomised, Double-Blind, Multi-Centre, Active Controlled Study to Evaluate the Efficacy Safety
- A 24-Month, Multi-Center, Randomized, Open-Label Non-Inferiostudy of Efficacy and Safety Comparing Two Exposures Of.....
- A 24-Wk, Plcbo-Contrld, Rndmzd, Parll Group Study Comparing Roflumilast 500 Mcg Daily V Plcbo on Pulmonary Function And
- A 26 Week Randomised, Multinational, Open Labelled, 2 Armed,Parallel Group, Treat-to-Target Once Daily Treatment . . .